Profile data is unavailable for this security.
About the company
Argent BioPharma Limited is a clinical-stage biopharmaceutical company pioneering nano-engineered therapeutics that reset the balance between the nervous and immune systems. The Company’s assets, CannEpil and CimetrA, target immune dysregulation in drug-resistant epilepsy and cytokine-driven inflammatory disorders, respectively. The Company’s proprietary delivery technologies enhance penetration across the blood-brain and alveolar-capillary barriers, supporting differentiated efficacy and composition-of-matter protection. It focuses on urgent unmet needs in the central nervous system (CNS) and systemic inflammation. Its product pipeline includes CimetrA, CannEpil, CogniCann and others. CannEpil is a refractory epilepsy seizure control treatment. CogniCann is an investigational oral spray developed by the Company to help manage symptoms associated with dementia and Alzheimer’s disease. The Company has a patient base in Australia, the United Kingdom, Brazil, and Ireland.
- Revenue in AUD (TTM)180.56k
- Net income in AUD-17.84m
- Incorporated2005
- Employees--
- LocationArgent Biopharma LtdSuite 1, 295 Rokeby RoadSUBIACO 6008AustraliaAUS
- Phone+61 86555-2950
- Fax+61 89389-2099
- Websitehttps://argentbiopharma.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hexima Ltd | 0.00 | -503.83k | 2.17m | -- | -- | -- | -- | -- | -0.0246 | -0.0246 | 0.00 | 0.0091 | 0.00 | -- | -- | -- | -26.34 | -72.86 | -28.49 | -144.87 | -- | -- | -- | -335.94 | -- | -- | 0.00 | -- | -100.00 | -- | 46.05 | -- | -- | -- |
| Argent BioPharma Ltd | 180.56k | -17.84m | 4.35m | -- | -- | -- | -- | 24.08 | -0.3292 | -0.3292 | 0.0032 | -0.1196 | 0.0272 | 0.2721 | 0.4238 | -- | -269.25 | -135.49 | -- | -380.42 | 24.06 | -45.51 | -9,882.75 | -764.45 | 0.1752 | -321.38 | -- | -- | -79.74 | -38.66 | -1.79 | -- | -70.28 | -- |
| BPH Global Ltd | 352.38k | -1.49m | 4.71m | 31.00 | -- | -- | -- | 13.36 | -0.0026 | -0.0026 | 0.0006 | -0.0014 | 0.8548 | 3.49 | 2.27 | -- | -360.76 | -76.32 | -- | -214.32 | 6.86 | 17.08 | -422.04 | -156.56 | 0.1995 | -43.14 | -- | -- | 220.43 | -13.56 | 24.87 | -- | -- | -- |
| Invion Ltd | 0.00 | -8.81m | 6.77m | 8.00 | -- | 0.8127 | -- | -- | -0.1183 | -0.1183 | 0.00 | 0.0972 | 0.00 | -- | -- | -- | -70.63 | -29.16 | -77.64 | -30.88 | -- | -- | -- | -147.34 | -- | -- | 0.00 | -- | -100.00 | -- | -56.50 | -- | -- | -- |
| Vectus Biosystems Ltd | 18.77k | -1.78m | 6.95m | -- | -- | -- | -- | 370.08 | -0.0334 | -0.0334 | 0.0004 | -0.0048 | 0.0134 | -- | 0.0266 | -- | -126.57 | -79.19 | -247.24 | -189.44 | -- | -- | -9,468.62 | -10,165.01 | 0.9301 | -554.06 | -- | -- | -75.58 | 73.61 | 23.99 | -- | -- | -- |
| Nexalis Therapeutics Ltd | 837.55k | -1.33m | 7.09m | -- | -- | -- | -- | 8.46 | -0.006 | -0.006 | 0.0037 | -0.0041 | 0.8301 | -- | 2.50 | -- | -131.43 | -73.85 | -- | -100.32 | -- | -- | -158.33 | -369.19 | -- | -- | -- | -- | -66.38 | 21.67 | 16.21 | -- | -- | -- |
| Percheron Therapeutics Ltd | 371.10k | -14.92m | 7.61m | 8.00 | -- | 0.7609 | -- | 20.51 | -0.0149 | -0.0149 | 0.0004 | 0.0092 | 0.0275 | -- | 0.2824 | -- | -110.67 | -79.28 | -153.98 | -96.61 | -- | -- | -4,021.00 | -3,694.96 | -- | -1,093.50 | 0.0026 | -- | -39.71 | 64.80 | -25.19 | -- | -6.74 | -- |
| Biotron Ltd | 0.00 | -318.57k | 8.11m | 4.00 | -- | 7.21 | -- | -- | -0.0004 | -0.0004 | 0.00 | 0.0004 | 0.00 | -- | -- | -- | -43.23 | -86.63 | -206.95 | -112.69 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 90.73 | -- | -- | -- |
